132 related articles for article (PubMed ID: 30041821)
1. PARP-1 inhibition attenuates cardiac fibrosis induced by myocardial infarction through regulating autophagy.
Wang H; Yang X; Yang Q; Gong L; Xu H; Wu Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1625-1632. PubMed ID: 30041821
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
3. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7.
Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y
Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-325 alleviates myocardial fibrosis after myocardial infarction via downregulating GLI1.
Wang CC; Shang BB; Yang CW; Liu YF; Li XD; Wang SY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5339-5346. PubMed ID: 30178860
[TBL] [Abstract][Full Text] [Related]
5. Taohong siwu decoction attenuates myocardial fibrosis by inhibiting fibrosis proliferation and collagen deposition via TGFBR1 signaling pathway.
Tan Z; Jiang X; Zhou W; Deng B; Cai M; Deng S; Xu Y; Ding W; Chen G; Chen R; Zhang S; Zhou Y; Liu B; Zhang J
J Ethnopharmacol; 2021 Apr; 270():113838. PubMed ID: 33460756
[TBL] [Abstract][Full Text] [Related]
6. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
7. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.
Zakaria EM; El-Bassossy HM; El-Maraghy NN; Ahmed AF; Ali AA
Eur J Pharmacol; 2016 Nov; 791():444-454. PubMed ID: 27612628
[TBL] [Abstract][Full Text] [Related]
9. Dengzhan Shengmai capsule attenuates cardiac fibrosis in post-myocardial infarction rats by regulating LTBP2 and TGF-β1/Smad3 pathway.
Wang M; Wang M; Zhao J; Xu H; Xi Y; Yang H
Phytomedicine; 2023 Jul; 116():154849. PubMed ID: 37163903
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity.
Sun S; Hu Y; Zheng Q; Guo Z; Sun D; Chen S; Zhang Y; Liu P; Lu J; Jiang J
J Cell Biochem; 2019 Apr; 120(4):4813-4826. PubMed ID: 29278652
[TBL] [Abstract][Full Text] [Related]
11. ATF3 affects myocardial fibrosis remodeling after myocardial infarction by regulating autophagy and its mechanism of action.
Huang Y; Dai H
Gene; 2023 Nov; 885():147705. PubMed ID: 37572799
[TBL] [Abstract][Full Text] [Related]
12. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction.
Carvalho A; Ji Z; Zhang R; Zuo W; Qu Y; Chen X; Tao Z; Ji J; Yao Y; Ma G
Int J Cardiol; 2023 Sep; 387():131128. PubMed ID: 37356730
[TBL] [Abstract][Full Text] [Related]
15. Danqi soft caspule prevents atrial fibrillation by ameliorating left atrial remodeling through inhibiting cardiac fibroblasts differentiation and function.
Ma J; Ren M; Li J; Zheng C; Chen Q; Ma S
Phytomedicine; 2022 Jul; 101():154134. PubMed ID: 35525237
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models.
Fan GP; Wang W; Zhao H; Cai L; Zhang PD; Yang ZH; Zhang J; Wang X
Cell Physiol Biochem; 2015; 37(2):515-26. PubMed ID: 26330161
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3-aminobenzamide on ventricular function in infarct heart assessed by quantitative tissue velocity imaging.
Wang M; Hu B; Zhang YL; Shen E; Pan XQ
J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):793-802. PubMed ID: 25000248
[TBL] [Abstract][Full Text] [Related]
19. Minocycline improves cardiac function after myocardial infarction in rats by inhibiting activation of PARP-1.
Zhao H; Zhang J; Hong G
Biomed Pharmacother; 2018 Jan; 97():1119-1124. PubMed ID: 29136949
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
Wang Y; Wang L; Zhang F; Zhang C; Deng S; Wang R; Zhang Y; Huang D; Huang K
Int J Cardiol; 2013 Sep; 167(5):2285-93. PubMed ID: 22846599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
